Adverse drug reaction of the month
Hypoparathyroidism unmasked by alendronate
A S Kashyapa, Surekha Kashyapb
a Armed Forces
Medical College, Pune 411 040, India: Department of Medicine, b Department of Hospital Administration
Correspondence to: Dr A S Kashyap (e-mail: skashyap{at}pn2.vsnl.net.in)
Submitted 6 June 1999;
Accepted 16 December 1999
The case of an elderly woman is reported in whom
alendronate, given for osteoporosis, led to severe hypocalcaemia a few
days after starting the drug treatment. This was caused by the
unmasking of previously unrecognised hypoparathyroidism.
Keywords: alendronate; hypocalcaemia; hypoparathyroidism
© 2000 by The Fellowship of Postgraduate Medicine
This article has been cited by other articles:
-
Maclsaac, R. J, Seeman, E., Jerums, G.
(2002). Seizures after alendronate. JRSM
95: 615-616
[Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
